126 - 150 of 55.749
- Product
- Maturity
- Leverage (Omega)
- Sell
- Buy
- Novo Nordisk Call 360,00 19 Mar 2027
- Goldman Sachs
- 19.03.27
- 3,54x
- Analysis
- Nike Call 64,00 17 Sep 2027
- Goldman Sachs
- 17.09.27
- 3,01x
- Analysis
- Nike Call 86,00 17 Jun 2027
- Goldman Sachs
- 17.06.27
- 3,71x
- Analysis
- Nike Call 68,00 17 Jun 2027
- Goldman Sachs
- 17.06.27
- 3,38x
- Analysis
- Novo Nordisk Call 290,00 19 Mar 2027
- Goldman Sachs
- 19.03.27
- 2,96x
- Analysis
- Nike Call 72,00 17 Jun 2027
- Goldman Sachs
- 17.06.27
- 3,41x
- Analysis
- Nike Call 82,00 17 Jun 2027
- Goldman Sachs
- 17.06.27
- 3,59x
- Analysis
- Nike Call 70,00 17 Jun 2027
- Goldman Sachs
- 17.06.27
- 3,39x
- Analysis
- Nike Call 78,00 17 Jun 2027
- Goldman Sachs
- 17.06.27
- 3,55x
- Analysis
- Nike Call 76,00 17 Jun 2027
- Goldman Sachs
- 17.06.27
- 3,58x
- Analysis
- Nike Call 74,00 17 Sep 2027
- Goldman Sachs
- 17.09.27
- 3,23x
- Analysis
- Nike Call 74,00 17 Jun 2027
- Goldman Sachs
- 17.06.27
- 3,51x
- Analysis
- Nike Call 62,00 17 Sep 2027
- Goldman Sachs
- 17.09.27
- 2,96x
- Analysis
- Nike Call 78,00 19 Mar 2027
- Goldman Sachs
- 19.03.27
- 4,10x
- Analysis
- Nike Call 82,00 19 Mar 2027
- Goldman Sachs
- 19.03.27
- 4,23x
- Analysis
- Nike Call 62,00 19 Mar 2027
- Goldman Sachs
- 19.03.27
- 3,53x
- Analysis
- Nike Call 58,00 17 Jun 2027
- Goldman Sachs
- 17.06.27
- 3,06x
- Analysis
- Nike Call 64,00 17 Jun 2027
- Goldman Sachs
- 17.06.27
- 3,24x
- Analysis
- Nike Call 84,00 19 Mar 2027
- Goldman Sachs
- 19.03.27
- 4,25x
- Analysis
- Nike Call 56,00 17 Jun 2027
- Goldman Sachs
- 17.06.27
- 3,01x
- Analysis
- Nike Call 68,00 19 Mar 2027
- Goldman Sachs
- 19.03.27
- 3,80x
- Analysis
- Nike Call 66,00 19 Mar 2027
- Goldman Sachs
- 19.03.27
- 3,70x
- Analysis
- Nike Call 80,00 19 Mar 2027
- Goldman Sachs
- 19.03.27
- 4,18x
- Analysis
- Novo Nordisk Call 390,00 17 Sep 2027
- Goldman Sachs
- 17.09.27
- 3,32x
- Analysis
- Nike Call 76,00 19 Mar 2027
- Goldman Sachs
- 19.03.27
- 3,99x
- Analysis